Scott B. Ullem Edwards Lifesciences Corp (EW) insider trading activity

Scott B. Ullem is CVP, Chief Financial Officer of Edwards Lifesciences Corp. Currently has a direct ownership of 30,561 shares of EW, which is worth approximately $2 Million. The most recent transaction as insider was on Aug 31, 2023, when has been sold 7,255 shares (Common Stock) at a price of $77.79 per share, resulting in proceeds of $564,366. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.6K

0% 3M change

58.77% 12M change

Total Value Held $2 Million

Scott B. Ullem Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2023	SELL Open market or private sale	$564,366 $77.79 p/Share	7,255 Reduced 27.37%	19,248 Common Stock
Aug 31 2023	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.49%	26,503 Common Stock
Jul 31 2023	SELL Open market or private sale	$611,959 $84.35 p/Share	7,255 Reduced 27.37%	19,248 Common Stock
Jul 31 2023	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.49%	26,503 Common Stock
Jun 30 2023	SELL Open market or private sale	$676,673 $93.27 p/Share	7,255 Reduced 27.37%	19,248 Common Stock
Jun 30 2023	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.49%	26,503 Common Stock
May 17 2023	SELL Bona fide gift	-	8,496 Reduced 30.62%	19,248 Common Stock
May 11 2023	BUY Grant, award, or other acquisition	-	9,450 Added 25.41%	27,744 Common Stock
May 10 2023	SELL Open market or private sale	$7,165,353 $88.79 p/Share	80,700 Reduced 81.52%	18,294 Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	$2,840,640 $35.2 p/Share	80,700 Added 44.91%	98,994 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$148,550 $88.74 p/Share	1,674 Reduced 8.38%	18,294 Common Stock
May 07 2023	SELL Payment of exercise price or tax liability	$266,574 $88.74 p/Share	3,004 Reduced 13.08%	19,968 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	6,062 Added 20.88%	22,972 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$38,852 $88.1 p/Share	441 Reduced 2.54%	16,910 Common Stock
May 03 2023	SELL Payment of exercise price or tax liability	$38,021 $87.81 p/Share	433 Reduced 2.43%	17,351 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$26,300 $78.51 p/Share	335 Reduced 1.85%	17,784 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	1,941 Added 9.68%	18,119 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$187,351 $95.93 p/Share	1,953 Reduced 6.26%	29,261 Common Stock
May 08 2022	SELL Payment of exercise price or tax liability	$877,339 $100.52 p/Share	8,728 Reduced 21.85%	31,214 Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	14,831 Added 27.08%	39,942 Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$77,601 $100.52 p/Share	772 Reduced 2.98%	25,111 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$46,715 $105.93 p/Share	441 Reduced 1.68%	25,883 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	5,000 Added 15.96%	26,324 Common Stock
Apr 04 2022	SELL Bona fide gift	-	15,488 Reduced 42.07%	21,324 Common Stock
Feb 21 2022	SELL Payment of exercise price or tax liability	$33,693 $105.62 p/Share	319 Reduced 0.86%	36,812 Common Stock

Also insider at

BERY

BERRY GLOBAL GROUP, INC. Consumer Cyclical

ILMN

ILLUMINA, INC. Healthcare

Director

SBU

Scott B. Ullem

CVP, Chief Financial Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account